Tags : Koch Disruptive Technologies

South East

Sense Biodetection secures £35.86 million Series B investment led by

Sense Raises $50m Series B to Accelerate Launch of COVID-19 molecular test on its Veros™ Instrument-Free Product Platform The investment led by Koch Disruptive Technologies helps Sense accelerate its portfolio of products to deliver patient-focused healthcare April 20, 2021 – Sense Biodetection (Sense), today announced that it has raised a $50m Series B investment to advance […]Read More